Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
ECRE Report: Study visit to Luxembourg on good practices in upholding the rights of asylum-seeking and refugee women and girls
European Council on Refugees and Exiles (ECRE)
In autumn 2025, ECRE and its partners from across Europe conducted a study visit to Luxembourg in order to examine national practices in safeguarding the rights of self-identified asylum-seeking and refugee women and girls.
Minister Fajon in Luxembourg: The EU must speak out against Israel’s human rights violations
Government of Slovenia
SLOVENIA, April 21 - We must not forget the situation in Gaza and the West Bank During the discussion on the Middle East, Minister Fajon recalled the joint initiative of the foreign ministers of Slovenia, Ireland and Spain, who called for EU...
Implicity secures $40M growth equity funding to scale its AI-driven cardiac monitoring platform globally
GlobeNewswire, Inc.
The round is led by growth fund IRIS alongside Five Arrows.
Nutraceutical Excipients Market: Powering the Future of Functional Health
GlobeNewswire, Inc.
Delray Beach, FL, April 15, 2026 (GLOBE NEWSWIRE) -- According to recent report published by MarketsandMarkets, the global nutraceutical excipients market is projected to grow from USD 4.98 billion in 2025 to USD 7.12 billion by 2030, registering...
ProFeel Life Establishes Itself as Switzerland's Specialist in Additive-Free Dietary Supplements
GlobeNewswire, Inc.
Collombey-Muraz, Valais (Switzerland), March 26, 2026 (GLOBE NEWSWIRE) -- ProFeel Life, a Swiss micronutrition platform and health media outlet based in Collombey, today announces the strengthening of its natural dietary supplement offering...
Ultragenyx Pharmaceutical Inc. Notice of April 6, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
GlobeNewswire, Inc.
NEW YORK and NEW ORLEANS, March 31, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Ultragenyx Pharmaceutical Inc. (“Ultragenyx” or the...
Ultragenyx Pharmaceutical Inc. Notice of April 6, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
GlobeNewswire, Inc.
NEW YORK and NEW ORLEANS, March 24, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Ultragenyx Pharmaceutical Inc. (“Ultragenyx” or the...
Ultragenyx Pharmaceutical Inc. Notice of April 6, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
GlobeNewswire, Inc.
NEW YORK and NEW ORLEANS, March 17, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Ultragenyx Pharmaceutical Inc. (“Ultragenyx” or the...
Ultragenyx Pharmaceutical Inc. Notice of April 6, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
GlobeNewswire, Inc.
NEW YORK CITY and NEW ORLEANS, March 10, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Ultragenyx Pharmaceutical Inc. (“Ultragenyx” or the...
Trimontium Provides $325 Million Flexible Capital Solution to Authentic Restaurant Brands
GlobeNewswire, Inc.
LONDON, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Trimontium, an institutionally backed alternative asset manager specialising in flexible capital solutions, today announced a $325 million bespoke capital solution for Authentic Restaurant Brands (“ARB”),...
Ultragenyx Pharmaceutical Inc. Notice of April 6, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
GlobeNewswire, Inc.
NEW YORK and NEW ORLEANS, March 03, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Ultragenyx Pharmaceutical Inc. (“Ultragenyx” or the...
Ardent Health Corporation Securities Fraud Class Action Result of Undisclosed Collections Problems and 33% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
GlobeNewswire, Inc.
NEW YORK and NEW ORLEANS, March 03, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until March 9, 2026 to...
ABL Luxembourg Executes First Purchase Notice With Alumni Capital Under Its Equity Line and Share Loan Agreement
EIN Presswire
First tranche completed with the sale of 128,026 ABL Diagnostics shares to Alumni Capital, marking the operational launch of the Agreement.
Ultragenyx Pharmaceutical Inc. Notice of April 6, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
GlobeNewswire, Inc.
NEW YORK and NEW ORLEANS, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Ultragenyx Pharmaceutical Inc. (“Ultragenyx” or the...
Ardent Health Corporation Securities Fraud Class Action Result of Undisclosed Collections Problems and 33% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
GlobeNewswire, Inc.
NEW YORK CITY and NEW ORLEANS, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until March 9,...
Ultragenyx Pharmaceutical Inc. Notice of April 6, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
GlobeNewswire, Inc.
NEW YORK and NEW ORLEANS, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Ultragenyx Pharmaceutical Inc. (“Ultragenyx” or the...
Ardent Health Corporation Securities Fraud Class Action Result of Undisclosed Collections Problems and 33% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
GlobeNewswire, Inc.
NEW YORK CITY and NEW ORLEANS, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until March 9,...
Ultragenyx Pharmaceutical Inc. Notice of April 6, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
GlobeNewswire, Inc.
NEW YORK CITY and NEW ORLEANS, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Ultragenyx Pharmaceutical Inc. (“Ultragenyx” or the...
AIM ImmunoTech Significantly Expands Ampligen® Global Patent Estate with Long COVID Protection Across Europe and the United Kingdom Through 2041
GlobeNewswire, Inc.
Patent protections establish long-duration intellectual property coverage for Ampligen across major European markets and the United Kingdom Latest milestone further strengthens AIM’s expanding global Ampligen patent estate across multiple...
Clinical Trial Platform Market - Opportunities, Share, Growth and Competitive Analysis and Forecast 2029
EIN Presswire
The Business Research Company's Clinical Trial Platform Market - Opportunities, Share, Growth and Competitive Analysis and Forecast 2029 LONDON, GREATER LONDON, UNITED KINGDOM, October 10, 2025 /EINPresswire.com/ -- "Get 20% Off All Global...
Sign up for:
Health Network Luxembourg
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.